Photo: Shutterstock

Big Phar­ma is rich. So much so, their cof­fers could buy more than 600 biotechs

The pan­dem­ic made Big Phar­ma even rich­er than be­fore as vac­cines and ther­a­peu­tics splashed on­to the mar­ket to the tune of bil­lions of dol­lars. In …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.